Stock screener

FDMT

Conviction 94HealthcareScan · Thu, Sep 24, 2026

4D Molecular Therapeutics, Inc. (FDMT) closed at $14.72 (-1.87%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 54, RS Rating 94, -12.2% from its 52-week high, +101.1% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

FDMT$14.72-1.87%
ResistanceSupportVol 14Insider sell
63 bars
2
Vol MA14 866.83K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
4D Molecular Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.4dmoleculartherapeutics.com ↗
Price14.72
Change-1.87%
Gap-1.03%
Rel volume1.71×
Avg volume894.28K
Avg $ vol13.06M
SMA 2014.50
SMA 5013.01
SMA 20010.34
Price vs 50+13.11%
Price vs 200+42.33%
MA stackbullish
50/200 cross—
Supertrendup · 12.95
RSI (14)54
MACD hist-0.01
MACD crossbear · 0d
Stoch %K / %D54 / 69
ADX (14)20
+DI / −DI23 / 23
RSI divergence—
MACD divergence—
ATR %6.88%
ADR %6.25%
52w high16.76
52w low7.19
From 52w high-12.17%
Above 52w low+104.73%
New 52w highNo
SqueezeOn · 1d
Bollinger width18.39%
%B0.58
Donchian pos54.10%
Donchian high16.23
Donchian low12.94
AVWAP (52w high)14.96
vs AVWAP high-1.62%
AVWAP (52w low)10.84
vs AVWAP low+35.85%
OBV trendFlat
Chaikin MF (20)0.04
Today vs 20d1.71×
Avg vol (14d)866.83K
Avg vol (20d)894.28K
Avg $ vol (20d)13.06M
Market cap732.73M
RS Rating94 / 99
RS 3m (vs SPY)+23.29%
RS 6m (vs SPY)+32.17%
RS line new highNo
Trend template8/8
Technical rank81.0
1 week+0.27%
1 month-6.36%
3 months+27.78%
6 months+48.99%
1 year+93.43%
YTD+101.09%
P/E-5.23
P/B1.80
P/S8.60
P/FCF-6.68
EPS-2.42
Div yield—
ROE-34.37%
ROA-28.44%
Debt/Eq0.05
Current8.03
EV/EBITDA-4.40
Gross margin—
Net margin-164.43%
Rev growth—
EPS growth12.90%
Price target32.00
Target upside117.39%
Analyst ratingBuy
Institutional120.64%
Ent. value681.95M
Revenue3.78M
Net income-72.94M
Gross profit—
Free cash flow-109.62M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out52.28M
Employees196
ListedFri, Dec 11, 2020
Free float50.43M
Float %88.3%
Short interest12.07M
Days to cover8.2d
Short volume49.1%
Squeeze score82 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.04 vs −$1.04
Last surprise0.0% beat
Setup gradeA+
Conviction94 / 100
Pattern quality—
Tech rank81.0 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.58
Support10.46
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FDMT

All disclosures →
No recent disclosed trades by Congress in FDMT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FDMT · open-market 4 sells

InsiderSideShares
Kirn David
See Remarks · Stock Option (Right to Buy) · 2026-08-19
Exercise50K
Kirn David
See Remarks · Common Stock · 2026-08-19
Sell25.93K
Kirn David
See Remarks · Common Stock · 2026-08-19
Sell43.15K
Kirn David
See Remarks · Common Stock · 2026-08-19
Exercise50K
Bizily Scott
Chief Legal Officer · Common Stock · 2026-08-17
Exercise1.64K
Bizily Scott
Chief Legal Officer · Stock Option (Right to Buy) · 2026-08-17
Exercise1.64K
Bizily Scott
Chief Legal Officer · Common Stock · 2026-08-17
Sell1.64K
Bizily Scott
Chief Legal Officer · Common Stock · 2026-08-13
Sell1.64K
Bizily Scott
Chief Legal Officer · Common Stock · 2026-08-13
Exercise1.64K
Bizily Scott
Chief Legal Officer · Stock Option (Right to Buy) · 2026-08-13
Exercise1.64K

SEC filings

EDGAR filings in FDMT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.